abrdn

Develops immunotherapies that selectively deplete cytotoxic T cells to treat autoimmune diseases

Develops programmable epigenetic medicines to treat genetic diseases like FSHD

Develops novel multifunctional antibodies for oncology and immunology & inflammation indications